138 related articles for article (PubMed ID: 31299263)
1. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.
Moro M; Di Paolo D; Milione M; Centonze G; Bornaghi V; Borzi C; Gandellini P; Perri P; Pastorino U; Ponzoni M; Sozzi G; Fortunato O
J Control Release; 2019 Aug; 308():44-56. PubMed ID: 31299263
[TBL] [Abstract][Full Text] [Related]
2. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
3. Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.
Yung BC; Li J; Zhang M; Cheng X; Li H; Yung EM; Kang C; Cosby LE; Liu Y; Teng L; Lee RJ
Mol Pharm; 2016 Feb; 13(2):653-62. PubMed ID: 26741162
[TBL] [Abstract][Full Text] [Related]
4. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
[TBL] [Abstract][Full Text] [Related]
5. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
6. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
Kasinski AL; Slack FJ
Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA delivery by cationic lipoplexes for lung cancer therapy.
Wu Y; Crawford M; Yu B; Mao Y; Nana-Sinkam SP; Lee LJ
Mol Pharm; 2011 Aug; 8(4):1381-9. PubMed ID: 21648427
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.
Fiori ME; Barbini C; Haas TL; Marroncelli N; Patrizii M; Biffoni M; De Maria R
Cell Death Differ; 2014 May; 21(5):774-82. PubMed ID: 24488097
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.
Zhong M; Ma X; Sun C; Chen L
Chem Biol Interact; 2010 Mar; 184(3):431-8. PubMed ID: 20097187
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
11. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
13. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.
Borzi C; Calzolari L; Centonze G; Milione M; Sozzi G; Fortunato O
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124991
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
[TBL] [Abstract][Full Text] [Related]
15. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
18. Cationic liposome mediated delivery of FUS1 and hIL-12 coexpression plasmid demonstrates enhanced activity against human lung cancer.
Ren J; Yu C; Wu S; Peng F; Jiang Q; Zhang X; Zhong G; Shi H; Chen X; Su X; Luo X; Zhu W; Wei Y
Curr Cancer Drug Targets; 2014; 14(2):167-80. PubMed ID: 24410728
[TBL] [Abstract][Full Text] [Related]
19. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
Qin Q; Wei F; Zhang J; Wang X; Li B
J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo.
Jiang Q; Yuan Y; Gong Y; Luo X; Su X; Hu X; Zhu W
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2951-2967. PubMed ID: 31654121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
